Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
Research
BioInvent Receives FDA Fast Track Designation for BI-1808 for the Treatment of Cutaneous T-cell Lymphoma
Lund, Sweden – April 29, 2025 – BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and deve…
Professional Education Webcasts
Myelodysplastic Syndromes: Diagnosis, Treatment, and Side Effect Management
This activity is intended for oncology nurse practitioners, nurses, and social workers involved in the care of patients with myelodysplastic syndromes…
Cafecito con LLS: Hablemos de Cáncer Pediátrico
¿Todavía tienes preguntas después de enterarse del cáncer de sangre de su hijo o hija? Les invito a que nos acompañe en este episodio de Cafecito con …
Professional Education Webcasts
Innovations in Blood Cancer Treatment: Navigating CAR T-cell and Bispecific Therapies
Live symposium was held during the Oncology Nursing Society’s (ONS) 50th Annual Congress on April 10, 2025.
Professional Education Webcasts
Multiple Myeloma (MM): Diagnosis, Treatment and Side Effect Management
This activity is intended for oncology nurse practitioners, nurses, and social workers involved in the care of patients with multiple myeloma (MM).
Research
Solu Therapeutics Closes $41M Series A Financing and Announces First Patient Dosed in Phase 1 Clinical Trial of STX-0712 in Patients with CMML
BOSTON, Mass – April 9, 2024 – Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunolog…
Professional Education Webcasts
Empoderando a los Promotores de Salud: Una Serie Educativa sobre los Cánceres de la Sangre
Estos videos en español están diseñados para fortalecer el conocimiento de los Promotores de Salud y conectar a las comunidades hispanas y latinas con…
For all media-related inquiries and interview requests please email
[email protected]
A Blood Cancer United representative will respond as soon as possible.
